Previous research has demonstrated overall poor complianceand adherence to injectable insulin regimens, with pain and the inconvenienceof injectable formulations being key contributors.4−6 Increasingly,insulin pumps are used by patients with T1DM to reduce the injectionburden associated with insulin delivery. This evidence concerns the gene INS and type 1 diabetes mellitus.